Cite

HARVARD Citation

    Cheminant, M. et al. (n.d.). KIR3DL2 IS EXPRESSED IN PERIPHERAL T‐CELL LYMPHOMAS AND MAY BE A THERAPEUTIC TARGET. Hematological oncology. pp. 204-205. [Online]. 
  
Back to record